Filter
846
Filtered Results: 846
Text search:
drug
prices
Featured
Recommendations
75
New Publications
260
Language
Document type
No document type
507
Studies & Reports
177
Guidelines
79
Strategic & Response Plan
38
Manuals
19
Fact sheets
8
Situation Updates
7
Training Material
4
Infographics
4
Resource Platforms
3
Countries / Regions
Global
34
India
32
Kenya
28
Uganda
21
Myanmar / Burma
21
South Africa
18
Nepal
17
Western and Central Europe
17
Liberia
16
Zambia
15
Malawi
15
Tanzania
13
Ukraine
13
Nigeria
12
Sierra Leone
11
Ghana
11
Bangladesh
11
Latin America and the Carribbean
11
Africa
11
Zimbabwe
9
Syria
9
Indonesia
9
Ethiopia
8
Philippines
8
Congo, Democratic Republic of
7
Namibia
7
Botswana
7
South–East Asia Region
7
Eastern Europe
7
Cameroon
6
Mozambique
6
Asia
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Venezuela
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Tajikistan
3
Moldova
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Colombia
2
Bolivia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Turkey
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Argentina
1
Peru
1
Brazil
1
Serbia
1
Libya
1
Sri Lanka
1
Chile
1
Eastern Europe and Central Asia
1
Bhutan
1
Palestine
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
85
Public Health
51
Key Resources
20
Pharmacy & Technologies
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
110
Mental Health
80
Pharmacy
59
TB
49
AMR
47
COVID-19
33
Global Health Education
20
NCDs
18
Conflict
15
Health Financing Toolbox
15
NTDs
11
Planetary Health
10
Disability
8
Ebola
8
Refugee
8
Rapid Response
6
Caregiver
6
Polio
4
Natural Hazards
3
Cholera
2
Volume 20, September
Global smart update
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school ...-use-prevention programmes, the
captive audience, and the popular perception that drug prevention
should start from schools, or the need to show that action is being
taken to control a serious social problem.
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin...
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyright
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Accessed: 28.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
